Constellation Pharmaceuticals
Barbara Brown is a Director at Constellation Pharmaceuticals, A MorphoSys Company, serving as a Global Patient Safety Product Leader. Barbara previously held positions at companies such as Verastem Oncology, BioBridges, FORUM Pharmaceuticals, Genzyme Corporation, and Misys Healthcare Systems. Barbara has a Bachelor of Science degree in Communicative Disorders and Psychology from the University of Wisconsin-Madison.
This person is not in any offices
Constellation Pharmaceuticals
1 followers
Advancing novel, small molecule treatments targeting epigenetic mechanisms in tumor and immune cells for the benefit of patients.